Stephen John Hill
Direktor/Vorstandsmitglied bei The University of Nottingham
Profil
Stephen John Hill was the founder of CellAura Technologies Ltd., a company founded in 2003, where he held the title of Pharmacology Director.
Currently, Mr. Hill is the Director at The University of Nottingham and a Trustee at the British Pharmacological Society since 2020.
Aktive Positionen von Stephen John Hill
| Unternehmen | Position | Beginn |
|---|---|---|
| The University of Nottingham | Direktor/Vorstandsmitglied | 11.01.2010 |
British Pharmacological Society
 British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Stephen John Hill
| Unternehmen | Position | Ende |
|---|---|---|
CellAura Technologies Ltd.
 CellAura Technologies Ltd. Pharmaceuticals: MajorHealth Technology CellAura Technologies Ltd. offers drug discovery services. It combines world-renowned expertise in synthetic chemistry and molecular pharmacology to produce fluorescent reagents as tracers for G-protein coupled receptors (GPCRs) and other common drug discovery target classes. The company was founded by Barrie Kellam, Stephen J. Hill and George Michael in 2003 and is headquartered in Nottingham, the United Kingdom. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
CellAura Technologies Ltd.
CellAura Technologies Ltd. Pharmaceuticals: MajorHealth Technology CellAura Technologies Ltd. offers drug discovery services. It combines world-renowned expertise in synthetic chemistry and molecular pharmacology to produce fluorescent reagents as tracers for G-protein coupled receptors (GPCRs) and other common drug discovery target classes. The company was founded by Barrie Kellam, Stephen J. Hill and George Michael in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |
